Acute and subacute effects of oropharyngeal sensory stimulation with TRPV1 agonists in older patients with oropharyngeal dysphagia: a biomechanical and neurophysiological randomized pilot study. (April 2019)
- Record Type:
- Journal Article
- Title:
- Acute and subacute effects of oropharyngeal sensory stimulation with TRPV1 agonists in older patients with oropharyngeal dysphagia: a biomechanical and neurophysiological randomized pilot study. (April 2019)
- Main Title:
- Acute and subacute effects of oropharyngeal sensory stimulation with TRPV1 agonists in older patients with oropharyngeal dysphagia: a biomechanical and neurophysiological randomized pilot study
- Authors:
- Tomsen, Noemí
Ortega, Omar
Rofes, Laia
Arreola, Viridiana
Martin, Alberto
Mundet, Lluís
Clavé, Pere - Abstract:
- Background: Older people with oropharyngeal dysphagia (OD) present a decline in pharyngeal sensory function. The aim of this proof-of-concept study was to assess the biomechanical and neurophysiological effects of acute and subacute oropharyngeal sensory stimulation with transient receptor potential vanilloid 1 (TRPV1) agonists (capsaicinoids) in older patients with OD. Methods: We studied the effect of a single dose versus multiple doses (2 weeks) of oral capsaicin treatment (10 –5 M) or placebo in 28 older patients with OD (81.2 ± 4.6 years) using videofluoroscopy (penetration-aspiration scale [PAS], timing of swallow response) and electroencephalography (EEG) (latency and amplitude of pharyngeal event-related potential [ERP]). Results: Acute stimulation by capsaicinoids 10 –5 M did not improve swallow function and did not produce significant changes in pharyngeal ERP. In contrast, after 10 days of treatment, patients presented a clinically relevant and statistically significant reduction in the laryngeal vestibule closure (LVC) time (22.5%, p = 0.042), and in the PAS (24.2%, p = 0.038), compared with the placebo group. EEG results showed a reduction in the latency of the N1 peak (28.6%, p = 0.007) and an increase of the amplitude of the P1-N2 (59.4%, p = 0.038) and the N2-P2 (43.6%, p = 0.050) peaks. We observed a strong and significant correlation between the reduction in the latency of the N1 peak and change in LVC time after subacute treatment ( r = 0.750, p = 0.003).Background: Older people with oropharyngeal dysphagia (OD) present a decline in pharyngeal sensory function. The aim of this proof-of-concept study was to assess the biomechanical and neurophysiological effects of acute and subacute oropharyngeal sensory stimulation with transient receptor potential vanilloid 1 (TRPV1) agonists (capsaicinoids) in older patients with OD. Methods: We studied the effect of a single dose versus multiple doses (2 weeks) of oral capsaicin treatment (10 –5 M) or placebo in 28 older patients with OD (81.2 ± 4.6 years) using videofluoroscopy (penetration-aspiration scale [PAS], timing of swallow response) and electroencephalography (EEG) (latency and amplitude of pharyngeal event-related potential [ERP]). Results: Acute stimulation by capsaicinoids 10 –5 M did not improve swallow function and did not produce significant changes in pharyngeal ERP. In contrast, after 10 days of treatment, patients presented a clinically relevant and statistically significant reduction in the laryngeal vestibule closure (LVC) time (22.5%, p = 0.042), and in the PAS (24.2%, p = 0.038), compared with the placebo group. EEG results showed a reduction in the latency of the N1 peak (28.6%, p = 0.007) and an increase of the amplitude of the P1-N2 (59.4%, p = 0.038) and the N2-P2 (43.6%, p = 0.050) peaks. We observed a strong and significant correlation between the reduction in the latency of the N1 peak and change in LVC time after subacute treatment ( r = 0.750, p = 0.003). Conclusions: After 2 weeks of treatment, oropharyngeal sensory stimulation with capsaicinoids induced cortical changes that were correlated with improvements in swallowing biomechanics in older patients with OD. These results further show that sensory stimulation by TRPV1 agonists can become a useful pharmacological treatment for older patients with OD. … (more)
- Is Part Of:
- Therapeutic advances in gastroenterology. Volume 12(2019)
- Journal:
- Therapeutic advances in gastroenterology
- Issue:
- Volume 12(2019)
- Issue Display:
- Volume 12, Issue 2019 (2019)
- Year:
- 2019
- Volume:
- 12
- Issue:
- 2019
- Issue Sort Value:
- 2019-0012-2019-0000
- Page Start:
- Page End:
- Publication Date:
- 2019-04
- Subjects:
- deglutition disorders -- neurophysiology -- oropharyngeal dysphagia -- therapeutics
Gastroenterology -- Periodicals
Digestive organs -- Diseases -- Treatment -- Periodicals
Gastrointestinal system -- Diseases -- Treatment -- Periodicals
Liver -- Diseases -- Treatment -- Periodicals
Pharmacology -- Periodicals
Gastroenterology -- Periodicals
Gastrointestinal Diseases -- therapy -- Periodicals
Liver Diseases -- therapy -- Periodicals
Pharmacology -- Periodicals
Gastroentérologie -- Périodiques
Appareil digestif -- Maladies -- Traitement -- Périodiques
Tractus gastro-intestinal -- Maladies -- Traitement -- Périodiques
Hépatologie -- Périodiques
Foie -- Maladies -- Périodiques
Pharmacologie -- Périodiques
616.3005 - Journal URLs:
- http://rave.ohiolink.edu/ejournals/issn/1756283x/ ↗
http://tag.sagepub.com/ ↗
http://www.uk.sagepub.com/home.nav ↗
http://www.tag.sagepub.com/ ↗ - DOI:
- 10.1177/1756284819842043 ↗
- Languages:
- English
- ISSNs:
- 1756-283X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 12115.xml